Consolidated Statement Of Profit Or Loss

Astellas Pharma Inc. - Filing #7551605

Concept 2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
374,990,000,000 JPY
381,791,000,000 JPY
Cost of sales
68,947,000,000 JPY
88,870,000,000 JPY
Gross profit
306,043,000,000 JPY
292,920,000,000 JPY
Selling, general and administrative expenses
168,182,000,000 JPY
153,396,000,000 JPY
Other income
3,915,000,000 JPY
16,291,000,000 JPY
Other expenses
23,061,000,000 JPY
38,436,000,000 JPY
Operating profit (loss)
45,794,000,000 JPY
33,147,000,000 JPY
Finance income
3,776,000,000 JPY
927,000,000 JPY
Finance costs
2,720,000,000 JPY
2,396,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
686,000,000 JPY
350,000,000 JPY
Profit (loss) before tax
46,850,000,000 JPY
31,679,000,000 JPY
Income tax expense
13,721,000,000 JPY
6,867,000,000 JPY
Profit (loss)
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
33,129,000,000 JPY
JPY
33,129,000,000 JPY
33,129,000,000 JPY
JPY
JPY
24,812,000,000 JPY
24,812,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
24,812,000,000 JPY
JPY
JPY
JPY
Profit (loss) attributable to
Owners of parent
33,129,000,000 JPY
24,812,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
18.46
13.59
Diluted earnings (loss) per share
18.42
13.59

Talk to a Data Expert

Have a question? We'll get back to you promptly.